author-photo

Séverine Metzger

14

Papers

75

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres†.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Abstract 3112: Prospective immune phenotyping of neuroblastoma children at diagnosis reveals specific immune defects related to the aggressiveness of the disease

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

2019 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (8)
BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for Chemosensitive Relapses in Patients with Follicular Lymphoma: A Prospective Multicenter Phase II Study from Lymphoma Study Association (LYSA) Centers

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso‐occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study

2018 Pain Practice
Show All
- Source
- Cite
- Save
Citations (5)
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

2018 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (41)
Efficacy and tolerance of Lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle-cell crises in children

2018
Show All
- Source
- Cite
- Save
Citations (0)
Pazopanib (P) and bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors: Phase I combination study final analysis.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

2017 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (4)